Business of Medicine
What do you do when the evidence doesn’t line up with the patient’s wishes?
Daily News Podcast
And atrial fibrillation guidelines may miss the mark with oral anticoagulation.
The proposal has spurred intense criticism from Democrats, anti-poverty activists, health care organizations, and immigrants’ rights advocates,...
The ACR, ASCO, AMA, and others argued against the proposal in comments to CMS.
The U.K. agency issued draft guidance recommending against use of tisagenlecleucel (Kymriah) a month after issuing similar guidance about...
From the Editor
Dr. Matt Kalaycio thought he was free of financial conflicts because he doesn’t take pharma money. Then he checked Open Payments.
Medicare officials are seeking input on how to revamp their competitive acquisition plan for Part B drugs.
Any barrier between the patient and the physician is bad, and two or three barriers makes things logarithmically worse.
“Balance billing is ripe for a federal solution,” Mr. Lucia said. States regulate only some plans, leaving “a vast number of people that aren’t...
From the Journals
The value proposition for the pricey CAR T-cell therapy depends on whether the real-world outcomes are as good as the ones seen in clinical trials...